Filter by
Filters
Filter results

Date

Primary topics

All topics

Types of content

All types

Products

All products

Diseases

All diseases

General Terms

All terms

Geography

All locations

Campaigns

All campaigns

Institutions & Events

All events and institutions
Apply
Clear all filters
199 results found
Report Cover Image
Letter |

Ukraine: Open Letter: Urgent action by Johnson & Johnson needed to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis

The Public Health Center of the Ministry of Ukraine (PHC) sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve equitable access to the lifesaving TB drug bedaquiline in ...
Tags Intellectual property and trade tuberculosis bedaquiline Johnson & Johnson Ukraine
Report cover image
Letter |

Moldova: Open Letter: CSOs request urgent action by Johnson & Johnson to improve equitable access to bedaquiline-based regimens in all countries with a high burden of tuberculosis

Civil society organisations, communities affected by tuberculosis (TB), and partner institutions in Moldova sent this open letter to the US pharmaceutical corporation Johnson & Johnson (J&J) requesting urgent action to improve ...
Tags Intellectual property and trade tuberculosis bedaquiline Johnson & Johnson Republic of Moldova
An MSF Health Promoter speaks with people about how to keep safe during the COVID-19 pandemic. Photograph by Tadeu Andre
Letter |
19 May 2020

South Africa’s patent laws threaten access to future COVID-19 medicines

In a letter to South African President Cyril Ramaphosa published today, the Fix the Patent Laws (FTPL) coalition outlined major concerns about the country's ability to access future treatments or vaccines for COVID-19. They point out that the country’s outdated patent laws ensure that when effective treatments become available, they will likely be too expensive and remain inaccessible to those in need.

Counting of medication Co-Trimoxizole at the HIV clinic at Madi Opei health centre, Kitgum District, Uganda, November 3, 2009.
Opinion article |

What Japanese government can and should do for the affordable medicines in the world

Japan, China, South Korea, India, Australia, and New Zealand together with the 10 ASEAN countries, which comprise the Regional Comprehensive Economic Partnership (RCEP), are meeting in Kobe this week to continue trade negotiations that ...
Tags Intellectual property and trade access to medicinesgeneric medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)